Gold, J; Marta, M; Meier, UC; Christensen, T; Miller, D; Altmann, D; Holden, D; Bianchi, L; Adiutori, R; MacManus, D; +4 more... Yousry, T; Schmierer, K; Turner, B; Giovannoni, G; (2018) A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study. Multiple sclerosis and related disorders, 24. pp. 123-128. ISSN 2211-0348 DOI: https://doi.org/10.1016/j.msard.2018.06.002

Altmann, DR; Button, T; Schmierer, K; Hunter, K; Tozer, DJ; Wheeler-Kingshott, CA; Coles, A; Miller, DH; (2013) Sample sizes for lesion magnetisation transfer ratio outcomes in remyelination trials for multiple sclerosis. Multiple sclerosis and related disorders, 3 (2). pp. 237-43. ISSN 2211-0348 DOI: https://doi.org/10.1016/j.msard.2013.09.007 Full text not available from this repository.

Altmann, DR; (2012) Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis-Sormani et al., Neurology 77, 2011. Multiple sclerosis and related disorders, 1 (3). pp. 109-10. ISSN 2211-0348 DOI: https://doi.org/10.1016/j.msard.2012.02.003 Full text not available from this repository.